1. Introduction {#sec1-ijerph-16-03050}
===============

Early diagnosis and improvements in cancer treatment have greatly enhanced the likelihood of cancer survival, and the number of cancer survivors is expected to reach 20 million by 2026 \[[@B1-ijerph-16-03050]\]. Since the National Institute of Medicine (IOM) reported on the importance of survivorship care \[[@B2-ijerph-16-03050]\], this issue has gradually attracted attention. Survivorship care has even been described as a paradigm shift in the cancer care continuum \[[@B3-ijerph-16-03050]\]. The follow-up period after cancer treatment is a distinct phase of care, involving psychosocial, community and supportive care, health promotion, regular monitoring, and long-term follow-up as well as interventions for late-effects \[[@B4-ijerph-16-03050],[@B5-ijerph-16-03050],[@B6-ijerph-16-03050]\].

Cancer care is a worldwide problem of considerable complexity and fragmentation \[[@B7-ijerph-16-03050],[@B8-ijerph-16-03050]\]. The fact that treatment can have a major impact on the long-term health and quality of life of survivors greatly complicates disease management, and the disease burden of survivors is often underestimated. Many patients with limited resources must deal with intermittent healthcare and compromised adherence to treatment regimes. In some cases, regular surveillance care in accordance with established guidelines is underused \[[@B9-ijerph-16-03050],[@B10-ijerph-16-03050]\]. In other cases, advanced imaging diagnostics (widely regarded as low-value care), are overused \[[@B9-ijerph-16-03050],[@B11-ijerph-16-03050],[@B12-ijerph-16-03050],[@B13-ijerph-16-03050]\]. The American Society of Clinical Oncology (ASCO) has listed the overuse of advanced imaging methods for breast cancer as one of the top five issues that must be addressed in efforts to improve the quality of cancer care and reduce the associated costs \[[@B14-ijerph-16-03050]\].

Continuity of care is concerned with the quality of care over time as well as fairness and efficiency \[[@B15-ijerph-16-03050],[@B16-ijerph-16-03050],[@B17-ijerph-16-03050],[@B18-ijerph-16-03050],[@B19-ijerph-16-03050],[@B20-ijerph-16-03050],[@B21-ijerph-16-03050],[@B22-ijerph-16-03050],[@B23-ijerph-16-03050]\]. Some empirical studies have surveyed care continuity from the perspective of cancer patients \[[@B23-ijerph-16-03050],[@B24-ijerph-16-03050],[@B25-ijerph-16-03050]\]. Previous research has indicated that higher care continuity is associated with a stronger sense of satisfaction, higher quality of life, and better mental health \[[@B19-ijerph-16-03050],[@B22-ijerph-16-03050]\]. Poor care continuity is associated with excessive consumption of medical resources, primarily through the consumption of unnecessary services \[[@B26-ijerph-16-03050]\].

One population-based study linked a lower oncology care continuity to a higher likelihood that breast cancer survivors would exceed the recommended number of visits to their oncologist \[[@B27-ijerph-16-03050]\]; however, there has been little research on the relationship between care continuity and health outcomes among cancer survivors empirically by using claims-based measurements. In addition, Taiwan has a unique medical environment which might undermine the care continuity \[[@B28-ijerph-16-03050]\]. The implementation of universal health insurance has greatly improved access to medical treatment in Taiwan; however, the family physician arrangement has not been formally implemented. This means that under the current scheme, patients may visit specialists without a referral \[[@B29-ijerph-16-03050]\].

Breast cancer is the most common form of cancer among women; however, the survival rate is relatively high \[[@B30-ijerph-16-03050]\]. Breast cancer survivors face multiple medical and psychosocial needs as they progress from treatment to survival \[[@B31-ijerph-16-03050]\]. Nonetheless, it has been shown that many breast cancer survivors do not receive adequate care \[[@B32-ijerph-16-03050],[@B33-ijerph-16-03050],[@B34-ijerph-16-03050],[@B35-ijerph-16-03050]\]. Therefore, we employed a nationally representative longitudinal database from the universal health insurance program in Taiwan to evaluate the effects of post-treatment care continuity on follow-up care utilization and health outcomes among breast cancer survivors in this study.

2. Methods {#sec2-ijerph-16-03050}
==========

2.1. Study Design, Data Resource, Participants {#sec2dot1-ijerph-16-03050}
----------------------------------------------

This retrospective cohort study was based on the long-form databases of the Taiwan Cancer Registry, comprising a nationally representative cohort of patients diagnosed with cancer \[[@B36-ijerph-16-03050],[@B37-ijerph-16-03050]\]. Patients newly diagnosed with breast cancer between January 1, 2002 and December 31, 2007 were included. Follow-up information extending until December 31, 2012 was obtained via data linkage using profiles from the National Healthcare Insurance Database (NHIRD) and the National Register of Deaths. Data resources were collected, organized, and managed by the Health and Welfare Data Science Center (HWDC) of the Ministry of Health and Welfare (MOHW). The index date for each patient in this study was set at 366 days post-diagnosis. The follow-up period was defined as the period from one year after the index date to four years after the index date (or sooner if censored), as this covers the period in which survivors are followed-up most intensively \[[@B27-ijerph-16-03050]\]. The recurrence or death during the follow-up period was considered as censored. This study was approved by the Institutional Review Board at the National Taiwan University Hospital (IRB approval number 201405054w), which waived the requirement for informed consent.

In accordance with previous studies \[[@B38-ijerph-16-03050],[@B39-ijerph-16-03050],[@B40-ijerph-16-03050],[@B41-ijerph-16-03050]\], patients were selected for inclusion based on the following criteria: (1) newly diagnosed with breast cancer, (2) confirmed diagnosis of cancer between 2002 and 2007, (3) diagnosis of Stage I--III breast cancer, (4) \>20 years old at the time of diagnosis, and (5) survived at least two years after diagnosis. Exclusion criteria included (1) missing information including age, gender, and date of cancer diagnosis date, and (2) receiving chemotherapy or radiation therapy during the follow-up period. Additionally, our focus in this study was on care continuity in the outpatient setting, and particularly in the second year after diagnosis during which survivors switch from treatment to follow-up care. Thus, cases without any outpatient records beyond the second year after diagnosis were also excluded. In order to avoid the problem of reverse causality, the care continuity was measured for one-year period and the measurement of follow-up care and health outcome was measured for a subsequent period ([Figure 1](#ijerph-16-03050-f001){ref-type="fig"}).

2.2. Variables {#sec2dot2-ijerph-16-03050}
--------------

### 2.2.1. Independent Variables {#sec2dot2dot1-ijerph-16-03050}

The independent variable was continuity of care between patients and their physician (solely for outpatient services) during the follow-up period. We adopted the continuity of care index (COCI) to calculate care continuity due to the larger number of physician visits typical of the Taiwanese healthcare system. The COCI derived from the number of different physicians visited and the number of visits made to each physician \[[@B42-ijerph-16-03050]\]. Note that this index is less sensitive to the number of visits to physicians \[[@B43-ijerph-16-03050]\].

The equation used to derive the index is as follows:$$COCI = \frac{\sum\limits_{j = 1}^{M}{n_{j}{}^{2} - N}}{N(N - 1)}$$ , where *N* represents the total number of primary care physician visits for a given patient, *n~j~* is the number of visits to the same physician j, and M is the total number of physicians for a given patient. COCI was calculated separately for primary care physicians (PCP) and oncology specialists. PCPs were physicians dealing with general medicine, internal medicine, family medicine, and obstetrics/gynecology \[[@B44-ijerph-16-03050],[@B45-ijerph-16-03050],[@B46-ijerph-16-03050]\]. Oncology specialists included subspecialists in medical oncology, hematology oncology, surgeons, or radiation oncologists.

COCI was calculated only for patients who made at least three visits, due to the fact that continuity of care would be meaningless if based a small number of visits \[[@B47-ijerph-16-03050],[@B48-ijerph-16-03050],[@B49-ijerph-16-03050]\]. COCI is bounded between 0 and 1, where a higher value indicates greater continuity of care. The value assigned for continuity of care has no inherent clinical meaning; therefore, we divided the sample into two groups (high and low continuity) based on the median COCI and distribution of scores across the entire study population. COCI was treated as time-varying variable for each year.

### 2.2.2. Dependent Variables {#sec2dot2dot2-ijerph-16-03050}

Measurements of follow-up care included the use of annual surveillance mammograms, breast ultrasounds, and advanced imaging tests for metastatic disease, which included chest X-rays, bone scans, liver ultrasound, computed tomography (CT) scans, positron emission tomography (PET) scans, and breast magnetic resonance imaging (MRI). The health outcomes included instances of hospital admission or emergency department visit in a given year. All outcome measures were coded as dichotomous variables.

### 2.2.3. Covariates {#sec2dot2dot3-ijerph-16-03050}

Patient characteristics included the year of diagnosis, age at the time of diagnosis, tumor stage, hormone receptor status, type of surgery, health status, occupation, and the level of insurance premiums. We used the modified Charlson Comorbidity Index (CCI) \[[@B50-ijerph-16-03050]\], the number of visits to physicians, and the likelihood of hospitalization for any reason in the year prior to breast cancer diagnosis as proxy variables for a patient health status. Modified CCI values were used to recalculate the score excluding cancer-related diagnoses. Regional characteristics included the level of urbanization and the number of physicians per square kilometer in the area of residence. The characteristics of the medical provider most frequently visited by the patient each year included the age of the physician and the average annual breast cancer volume of the physician. The characteristics of the medical institution most frequently visited by the patient each year included the accreditation level, ownership, and average annual breast cancer volume of the facility.

2.3. Statistical Analysis {#sec2dot3-ijerph-16-03050}
-------------------------

In cases of bivariate analysis, the chi-square test was used for the analysis of categorical variables. The continuous variable was first checked using the Kolmogorov--Smirnov test for normality. If the data presented normal distribution, then the Student's t-test was used; otherwise, the Mann--Whitney U Test was used. Additionally, we used propensity score matching (PSM) to minimize confounding effects \[[@B51-ijerph-16-03050]\]. In estimating propensity scores for oncology care continuity and PCP care continuity, the variables used in the logistic regression models included patient characteristics (year of diagnosis, age, tumor stage, hormone receptor status, type of surgical procedure, health status, and socioeconomic variables), regional characteristics (urbanization and number of physicians per square kilometer in area of patient residence), physician characteristics (age, average annual breast cancer volume), and the hospital characteristics (accreditation level, ownership, and average annual breast cancer volume).

Data were randomized using nearest neighbor matching, matching without replacement, and the tolerable caliper width was set at 0.001. After matching, the sample was analyzed in terms of standardized difference to determine whether the distribution of data was balanced. Generalized estimating equations (GEEs) were used for data analysis in order to control for subject characteristics that were not observed during the study, such as healthcare-seeking behavior. Note that GEE methods are commonly used for the analysis of correlated data to obtain unbiased estimates of coefficients despite possible misspecification of the correlation structure \[[@B52-ijerph-16-03050]\]. To avoid over-adjustment, we opted not to include in our analysis any variables that had been used in propensity score matching and had been balanced after matching.

3. Results {#sec3-ijerph-16-03050}
==========

3.1. Patient Characteristics {#sec3dot1-ijerph-16-03050}
----------------------------

This study included patients newly diagnosed with breast cancer (Stage I, II, or III) between 2002 and 2007. A total of 18,031 patients were included in the analysis. [Table 1](#ijerph-16-03050-t001){ref-type="table"} presents the distribution of baseline characteristics of the sample grouped according to the continuity of oncology care. Among breast cancer survivors with higher continuity of oncology care, the average age at the time of diagnosis was 51.7 years with the age distribution peaking at 45--54 years (37%), followed by 35--44 years old (22%), and 55--64 years (21%). In terms of clinical characteristics, most of the tumors were in Stage II (48%), followed by Stage I (34%). The estrogen receptor (ER)-positive rate was 52%, and progesterone receptor (PR)-positive rate was 47%. Approximately 25% of the patients underwent breast conserving surgery (BCS). In terms of basic health status, the CCI score of most of the patients was 0 (80%) or 1 (13%), and 16% were hospitalized one year prior to diagnosis. The occupation of most of the patients fell within the category of labor (31%). It was observed that 2% of the patients were physicians or family members of physicians. Most of the patients resided in urban areas (69%). The facilities most frequently visited by patients in the second year after diagnosis were medical centers (55%), most of which were non-public hospitals (80%). The physicians most frequently visited by patients were 40--59 years old (74%). Following PSM, the distributions of the variables were balanced.

[Table 2](#ijerph-16-03050-t002){ref-type="table"} presents the distribution of baseline characteristics of the sample grouped according to continuity of care by primary physicians (PCP). At the time of diagnosis, the average age of breast cancer survivors experiencing high continuity of primary care was 54.9 years with the age distribution peaking at 45--54 years (34%) followed by 55--64 years (26%). In terms of clinical characteristics, most of the tumors were in Stage II (47%) followed by Stage I (34%). The proportion of ER-positive results was 47%, and the proportion of PR-positive results was 42%. BCS accounted for 28% of the surgical procedures. In terms of basic health status, most of the patients had CCI scores of 0 (72%) or 1 (20%), and 16% were hospitalized during the year prior to diagnosis. Most of the patients were unemployed (28%) or categorized as labor (27%). It was observed that 1.6% of the patients were physicians or family members of physicians. Most of the patients resided in urban areas (65%). The hospitals most frequently visited in the second year after diagnosis were medical centers (66%), most of which were non-public hospitals (81%). The physicians most frequently visited by patients were between 40--59 years (74%). Following PSM, the distributions of the variables were balanced.

3.2. Distribution of Care Continuity, Follow-Up Care, and Health Outcome {#sec3dot2-ijerph-16-03050}
------------------------------------------------------------------------

[Table 3](#ijerph-16-03050-t003){ref-type="table"} presents the values of ambulatory care continuity, the percentage of follow-up service utilization, and negative health outcomes in the various follow-up periods. The average continuity of oncology care value was 0.70--0.72, and the average continuity of PCP care value was 0.52--0.54. In terms of follow-up services, 56--57% of the breast cancer survivors underwent mammography and 73--75% underwent breast ultrasound. Advanced imaging tests were administered to 82--85% of the patients. In terms of health outcomes, 11--13% of the patients were hospitalized and 12--15% visited the emergency department in each of the years ([Table 3](#ijerph-16-03050-t003){ref-type="table"}).

3.3. Effect of Oncology Care Continuity and PCP Care Continuity {#sec3dot3-ijerph-16-03050}
---------------------------------------------------------------

[Table 4](#ijerph-16-03050-t004){ref-type="table"} lists sample analysis after PSM. The distribution of each variable was balanced; therefore, we did not include the covariates used for adjustment; i.e., the table presents crude odds ratios). In terms of follow-up care utilization, breast cancer survivors with a higher oncology COCI was more likely to use mammography (OR = 1.26, 95% CI: 1.19--1.32), breast ultrasound (OR = 1.12, 95% CI: 1.06--1.18), or advanced imaging tests (OR = 1.47, 95% CI: 1.36--1.60). Primary care COCI was not associated with the use of these services. In terms of health outcomes, a higher oncology COCI was associated with a lower likelihood of hospitalization (OR = 0.78, 95% CI: 0.71--0.85) and lower likelihood of emergency department use (OR = 0.88, 95% CI: 0.82--0.95). Similarly, a higher primary care COCI was associated with lower likelihood of hospitalization (OR = 0.77, 95% CI: 0.70--0.85) and lower likelihood of emergency department use (OR = 0.75, 95% CI: 0.68--0.82). In addition, we used subgroup analysis to explore the potential effects of other variables on the association between continuity of care and the likelihood of adverse health events. The results are presented in [Appendix A](#app1-ijerph-16-03050){ref-type="app"}, [Figure A1](#ijerph-16-03050-f0A1){ref-type="fig"}.

4. Discussion {#sec4-ijerph-16-03050}
=============

This study examined the correlations between ambulatory continuity of care (by oncologists and primary care physicians) and the utilization of follow-up care by breast cancer survivors and their health outcomes.

Existing guidelines suggest that breast cancer survivors regularly undergo mammography in the first five years of the follow-up period; however, only 56%--57% of breast cancer survivors in this study actually undergo annual mammography during that period. The use of mammography by breast cancer survivors was estimated at 41% in South Korea \[[@B53-ijerph-16-03050]\], 54% in the UK \[[@B34-ijerph-16-03050]\], and 47%--82% in the US \[[@B9-ijerph-16-03050],[@B44-ijerph-16-03050],[@B46-ijerph-16-03050],[@B54-ijerph-16-03050],[@B55-ijerph-16-03050]\]. Considering the fear of pain caused by mammography and the higher density of breast tissue in Asian women, it is not uncommon for clinicians to opt for breast ultrasound as an alternative for follow-up monitoring. We discovered that 80% of the breast cancer survivors underwent mammography or breast ultrasonography in each year of the follow-up period.

On the other hand, we observed that 80% of breast cancer survivors used advanced imaging tests that were not recommended in current guidelines. Based on a review of medical records, Hahn et al. reported that 55% of breast cancer survivors in the US underwent at least one imaging examination that was not recommended for the monitoring of cancer status \[[@B22-ijerph-16-03050]\]. Note that we were unable to confirm the purpose of using the various examinations with administrative datasets; therefore, the relevant proportion may be overestimated. This type of imaging test exposes the patient to unnecessary high doses of radiation and many imaging tests are prone to false positive results, which can lead to anxiety and in some cases unnecessary invasive treatment \[[@B14-ijerph-16-03050]\]. In one study, it was surmised that the use of unnecessary imaging tests can be attributed to requests from patients for more aggressive examinations \[[@B56-ijerph-16-03050]\].

In the current study, the average ambulatory COCI values were as follows: oncology specialists (0.71) and primary care physicians (0.54). In relevant empirical studies on chronic diseases in the past, the mean COCI of outpatient care provided by physicians was 0.66 for asthma patients \[[@B57-ijerph-16-03050]\], 0.55--0.79 for patients with chronic obstructive pulmonary disease \[[@B57-ijerph-16-03050],[@B58-ijerph-16-03050],[@B59-ijerph-16-03050]\], 0.33--0.55 for patients with chronic heart failure \[[@B60-ijerph-16-03050]\], 0.50--0.71 for patients with diabetes \[[@B58-ijerph-16-03050]\], and 0.74 for patients with hypertension \[[@B57-ijerph-16-03050]\]. Continuity of care is related to disease characteristics; therefore, patients requiring long-term treatment and follow-up tend to have better ambulatory continuity of care \[[@B59-ijerph-16-03050]\]. The higher COCI values observed in this study may correlate with the risk of recurrence and the requirements of health management (e.g., dealing with late-effect symptoms). Anxiety about recurrence often prompts breast cancer survivors to seek follow-up support from oncologists \[[@B61-ijerph-16-03050]\].

Our results revealed that patients who continued to receive care from their oncologist were more likely to use mammography and/or breast ultrasonography, whereas patients who received follow-up care from their primary care physician were not likely to do so. Additionally, our results indicate that continuity of care, no matter for oncologists or for PCP, is negatively associated with hospitalization and emergency department visits. This result is consistent with the influence direction reported in previous studies \[[@B20-ijerph-16-03050],[@B62-ijerph-16-03050],[@B63-ijerph-16-03050],[@B64-ijerph-16-03050],[@B65-ijerph-16-03050],[@B66-ijerph-16-03050]\]. Continuity of care can promote a willingness on the part of patients to communicate disease-related information. It also makes it easier for patients and their families to deal with the disease. It appears that continuity of care can alter the health behavior of patients \[[@B67-ijerph-16-03050]\]. A good physician--patient relationship may increase the likelihood that the patient will seek medical help before the condition becomes urgent, thereby reducing the possibility of hospital admission or emergency department use. Long-term physician--patient relationships also make it easier for the physician to understand changes in the health status and needs of the patient. Patients who feel trust and satisfaction with their physician are more likely to comply with disease management instructions, such as compliance in taking medication \[[@B68-ijerph-16-03050]\]. At the provider level, regular care is highly conducive to information continuity. Lack of care continuity has been associated with a higher number of medical errors, such as duplicate medication and inappropriate medication \[[@B49-ijerph-16-03050],[@B69-ijerph-16-03050],[@B70-ijerph-16-03050]\].

This study has several limitations. First, the secondary database used in this study did not include clinical test values or data pertaining to comprehensive health status (e.g., awareness and physiological functions), socio-economic status (e.g., education level and actual income), health literacy, social network, psychological support resources, diet or exercise, or the life style choices of breast cancer survivors. We were also unable to confirm the care decision-making process, which made it impossible to determine whether the use of care services was related to the attitudes of health care providers or patient preferences. Furthermore, our use of the National Health Insurance Research Database made it impossible to obtain relevant information on self-paid health examinations from other archives. We were unable to confirm the reasons for using the various imaging tests; i.e., it is difficult to distinguish between surveillance and diagnostic procedures. This increases the likelihood that we overestimated the use of low-value (non-recommended) imaging diagnostics. Third, the indicators of continuity of care adopted in this study reflect only the degree to which patients sought medical care from regular medical providers. Thus, it was not possible for us to examine the variables related to physician--patient relationships, communication, and trust. Our analysis was also limited to physicians, such that the characteristics of the entire medical team could not be taken into consideration. Finally, it is possible that the influence of continuity of care may vary over time. This issue could be addressed in future studies.

5. Conclusions {#sec5-ijerph-16-03050}
==============

This study provides evidence that breast cancer survivors receiving ambulatory care continuity are more likely to use recommended surveillance care services and less likely to experience negative health events. Maintaining regular source of care should be adequately addressed in the post-treatment phase of cancer care.
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###### 

Baseline characteristics of patients grouped according to the oncology continuity of care.

  Characteristics                                        Pre-PSM Sample ^a^   Post-PSM Sample                                                          
  ------------------------------------------------------ -------------------- ----------------- ------ ------- -- -------- --------- ------ ------- -- --
                                                         *n*                  \%                *n*    \%         *n*      \%        *n*    \%         
  Year of diagnosis                                      0.0064                                                   0.9913   0.005                       
  2002                                                   274                  3.84              219    3.07       202      3.64      194    3.50       
  2003                                                   379                  5.31              334    4.69       281      5.07      274    4.94       
  2004                                                   1304                 18.28             1363   19.12      1035     18.67     1034   18.65      
  2005                                                   1447                 20.29             1568   21.99      1185     21.37     1189   21.44      
  2006                                                   1706                 23.92             1680   23.57      1316     23.73     1340   24.17      
  2007                                                   2023                 28.36             1965   27.56      1526     27.52     1514   27.30      
  Age of diagnosis                                       \<0.0001                                                 0.9199   --0.005                     
  \<35                                                   326                  4.57              310    4.35       244      4.40      254    4.58       
  35--44                                                 1765                 24.74             1597   22.40      1293     23.32     1306   23.55      
  45--54                                                 2714                 38.05             2662   37.34      2115     38.14     2081   37.53      
  55--64                                                 1452                 20.36             1508   21.15      1131     20.4      1139   20.54      
  65--74                                                 654                  9.17              790    11.08      563      10.15     581    10.48      
  75+                                                    222                  3.11              262    3.68       199      3.59      184    3.32       
  Stage                                                  0.0010                                                   0.9819   0.001                       
  I                                                      2469                 34.61             2446   34.31      1925     34.72     1918   34.59      
  II                                                     3222                 45.17             3398   47.66      2552     46.02     2562   46.20      
  III                                                    1442                 20.22             1285   18.02      1068     19.26     1065   19.21      
  ER                                                     0.0219                                                   0.9362   --0.006                     
  Negative                                               1417                 19.87             1307   18.33      1058     19.08     1073   19.35      
  Positive                                               3541                 49.64             3685   51.69      2835     51.13     2827   50.98      
  Unknown                                                2175                 30.49             2137   29.98      1652     29.79     1645   29.67      
  PR                                                     0.0004                                                   0.876    0.002                       
  Negative                                               1802                 25.26             1625   22.79      1343     24.22     1326   23.91      
  Positive                                               3156                 44.25             3362   47.16      2549     45.97     2575   46.44      
  Unknown                                                2175                 30.49             2142   30.05      1653     29.81     1644   29.65      
  Type of surgery                                        \<0.0001                                                 0.548    --0.011                     
  BCS                                                    2590                 36.31             1784   25.02      1680     30.3      1651   29.77      
  Else                                                   4543                 63.69             5345   74.98      3865     69.7      3894   70.23      
  CCI score                                              0.1164                                                   0.7611   --0.009                     
  0                                                      5661                 79.36             5730   80.38      4418     79.68     4429   79.87      
  1                                                      968                  13.57             955    13.40      749      13.51     757    13.65      
  2+                                                     504                  7.07              444    6.23       378      6.82      359    6.47       
  Prior hospitalization                                  0.1088                                                   0.6401   0.009                       
  Yes                                                    1083                 15.18             1152   16.16      872      15.73     890    16.05      
  No                                                     6050                 84.82             5977   83.84      4673     84.27     4655   83.95      
  Number of outpatient visits                            \<0.0001                                                 0.9904   0.000                       
  Low                                                    1808                 25.35             2077   29.13      1521     27.43     1518   27.38      
  Median                                                 2491                 34.92             2620   36.75      1964     35.42     1971   35.55      
  High                                                   2834                 39.73             2432   34.11      2060     37.15     2056   37.08      
  Level of insurance premiums                            \<0.0001                                                 0.9574   --0.009                     
  Low                                                    1523                 21.35             1552   21.77      1205     21.73     1212   21.86      
  Mid-Low                                                1910                 26.78             2120   29.74      1544     27.84     1560   28.13      
  Mid-High                                               1489                 20.87             1493   20.94      1153     20.79     1156   20.85      
  High                                                   2211                 31.00             1964   27.55      1643     29.63     1617   29.16      
  Occupation status                                      0.0002                                                   0.8437   0.004                       
  Labor                                                  2362                 33.11             2187   30.68      1727     31.15     1768   31.88      
  Public servant                                         1868                 26.19             1905   26.72      1510     27.23     1474   26.58      
  Farmer or fishermen                                    861                  12.07             1018   14.28      714      12.88     723    13.04      
  Low-income households ^b^                              64                   0.90              48     0.67       57       1.03      43     0.78       
  Unemployed                                             1978                 27.73             1971   27.65      1537     27.72     1537   27.72      
  Whether physicians/family members of physicians        0.8187                                                   0.7476   --0.006                     
  Yes                                                    151                  2.12              147    2.06       126      2.27      121    2.18       
  No                                                     6982                 97.88             6982   97.94      5419     97.73     5424   97.82      
  Urbanization                                           \<0.0001                                                 0.9834   0.000                       
  Low                                                    1972                 27.65             2207   30.96      1638     29.54     1639   29.56      
  High                                                   5161                 72.35             4922   69.04      3907     70.46     3906   70.44      
  Number of physicians per square kilometer              \<0.0001                                                 0.8113   --0.008                     
  Low                                                    3357                 47.07             3612   50.67      2717     49.00     2754   49.67      
  High                                                   3776                 52.94             3517   49.33      2828     51.00     2791   50.33      
  Age of physician                                       0.0002                                                   0.9917   0.001                       
  \<40                                                   1553                 21.77             1439   20.19      1162     20.96     1157   20.87      
  40--59                                                 5132                 71.95             5251   73.66      4056     73.15     4062   73.26      
  60+                                                    448                  6.28              439    6.16       327      5.90      326    5.88       
  Average annual breast cancer volume of the physician   \<0.0001                                                 0.8578   --0.008                     
  Low                                                    3972                 55.68             3145   44.12      2789     50.30     2801   50.51      
  Median                                                 1383                 19.39             2198   30.83      1299     23.43     1312   23.66      
  High                                                   1778                 24.93             1786   25.05      1457     26.28     1432   25.83      
  Accreditation level                                    0.0595                                                   0.8045   0.005                       
  Medical center                                         3799                 53.26             3909   54.83      2962     53.42     2975   53.65      
  Non-medical center                                     3334                 46.74             3220   45.17      2583     46.58     2570   46.35      
  Ownership                                              \<0.0001                                                 0.5364   --0.012                     
  Public hospital                                        2192                 30.73             1423   19.96      1372     24.74     1344   24.24      
  Non-public hospital                                    4941                 69.27             5706   80.04      4173     75.26     4201   75.76      
  Average annual breast cancer volume of the facility    \<0.0001                                                 0.7792   --0.012                     
  Low                                                    3179                 44.57             3506   49.18      2618     47.21     2638   47.57      
  Median                                                 2065                 28.95             2231   31.29      1669     30.10     1680   30.30      
  High                                                   1889                 26.48             1392   19.53      1258     22.69     1227   22.13      

PSM: propensity score matching; COCI: continuity of care index; ER: estrogen receptor; PR:progesterone receptor; CCI: Charlson comorbidity index; BCS: breast cancer surgery. ^a^ The analytic sample included only the patients who made at least 3 visits for oncologists in the second year after diagnosis. ^b^ Insured income is lower than the level required for charging premium.
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###### 

Baseline characteristics of patients grouped according to the PCP continuity of care.

  Characteristics                                        Pre-PSM Sample ^a^   Post-PSM Sample                                                        
  ------------------------------------------------------ -------------------- ----------------- ------ ------- -- -------- ------- ------ ------- -- --
                                                         *n*                  \%                *n*    \%         *n*      \%      *n*    \%         
  Year of diagnosis                                      0.0025                                                   0.9954   0.006                     
  2002                                                   122                  3.99              123    3.91       100      3.9     106    4.13       
  2003                                                   212                  6.93              196    6.24       164      6.39    164    6.39       
  2004                                                   652                  21.32             625    19.89      526      20.51   530    20.66      
  2005                                                   728                  23.81             662    21.06      583      22.73   579    22.57      
  2006                                                   624                  20.41             670    21.32      546      21.29   533    20.78      
  2007                                                   720                  23.54             867    27.59      646      25.19   653    25.46      
  Age of diagnosis                                       0.0683                                                   0.9942   0.001                     
  \<35                                                   85                   2.78              70     2.23       66       2.57    62     2.42       
  35--44                                                 507                  16.58             507    16.13      412      16.06   415    16.18      
  45--54                                                 1016                 33.22             1065   33.88      851      33.18   862    33.61      
  55--64                                                 727                  23.77             830    26.41      650      25.34   634    24.72      
  65--74                                                 514                  16.81             473    15.05      416      16.22   421    16.41      
  75+                                                    209                  6.83              198    6.30       170      6.63    171    6.67       
  Stage                                                  0.0961                                                   0.7737   0.019                     
  I                                                      1114                 36.43             1075   34.20      913      35.59   896    34.93      
  II                                                     1421                 46.47             1478   47.03      1202     46.86   1201   46.82      
  III                                                    523                  17.10             590    18.77      450      17.54   468    18.25      
  ER                                                     0.0028                                                   0.871    0.015                     
  Negative                                               761                  24.89             705    22.43      607      23.66   594    23.16      
  Positive                                               1482                 48.46             1485   47.25      1240     48.34   1239   48.3       
  Unknown                                                815                  26.65             953    30.32      718      27.99   732    28.54      
  PR                                                     0.0034                                                   0.7007   0.021                     
  Negative                                               906                  29.63             855    27.21      742      28.93   715    27.88      
  Positive                                               1337                 43.72             1333   42.41      1104     43.04   1117   43.55      
  Unknown                                                815                  26.65             955    30.38      719      28.03   733    28.58      
  Type of surgery                                        0.7421                                                   0.9007   0.003                     
  BCS                                                    855                  27.96             867    27.59      713      27.8    709    27.64      
  Else                                                   2203                 72.04             2276   72.41      1852     72.2    1856   72.36      
  CCI score                                              0.0019                                                   0.973    0.007                     
  0                                                      2107                 68.90             2261   71.94      1794     69.94   1801   70.21      
  1                                                      629                  20.57             629    20.01      523      20.39   520    20.27      
  2+                                                     322                  10.53             253    8.05       248      9.67    244    9.51       
  Prior hospitalization                                  0.0755                                                   0.5019   0.019                     
  Yes                                                    537                  17.56             499    15.88      441      17.19   423    16.49      
  No                                                     2521                 82.44             2644   84.12      2124     82.81   2142   83.51      
  Number of outpatient visits                            \<0.0001                                                 0.7804   0.017                     
  Low                                                    843                  27.57             1056   33.60      763      29.75   774    30.18      
  Median                                                 1081                 35.35             1100   35.00      901      35.13   914    35.63      
  High                                                   1134                 37.08             987    31.40      901      35.13   877    34.19      
  Level of insurance premiums                            0.0009                                                   0.909    0.008                     
  Low                                                    768                  25.11             777    24.72      665      25.93   655    25.54      
  Mid-Low                                                749                  24.49             691    21.99      593      23.12   604    23.55      
  Mid-High                                               823                  26.91             803    25.55      678      26.43   662    25.81      
  High                                                   718                  23.48             872    27.74      629      24.52   644    25.11      
  Occupation status                                      0.0018                                                   0.9864   0.010                     
  Labor                                                  719                  23.51             850    27.04      619      24.13   634    24.72      
  Public servant                                         775                  25.34             799    25.42      654      25.50   643    25.07      
  Farmer or fishermen                                    664                  21.71             575    18.29      510      19.88   506    19.73      
  Low-income households ^b^                              35                   1.14              41     1.30       35       1.36    33     1.29       
  Unemployed                                             829                  27.94             914    28.26      747      29.12   749    29.20      
  Whether physicians/family members of physicians        0.1581                                                   0.8071   0.007                     
  Yes                                                    35                   1.14              49     1.56       33       1.29    35     1.36       
  No                                                     3023                 98.86             3094   98.44      2532     98.71   2530   98.64      
  Urbanization                                           0.0610                                                   0.7276   0.010                     
  Low                                                    1151                 37.64             1111   35.35      938      36.57   926    36.10      
  High                                                   1907                 62.36             2032   64.65      1627     63.43   1639   63.90      
  Number of physicians per square kilometer              0.2812                                                   0.8736   0.014                     
  Low                                                    1554                 50.82             1529   48.65      1266     49.35   1270   49.52      
  High                                                   1504                 49.18             1614   51.35      1299     50.65   1295   50.48      
  Age of physician                                       \<0.0001                                                 0.899    0.012                     
  \<40                                                   645                  21.09             550    17.50      509      19.84   502    19.57      
  40--59                                                 2202                 72.01             2313   73.59      1865     72.71   1864   72.67      
  60+                                                    211                  6.90              280    8.91       191      7.45    199    7.76       
  Average annual breast cancer volume of the physician   \<0.0001                                                 0.8736   0.014                     
  Low                                                    1370                 44.80             1731   55.07      1271     49.55   1289   50.25      
  Median                                                 746                  24.40             799    25.42      672      26.2    666    25.96      
  High                                                   942                  30.80             613    19.50      622      24.25   610    23.78      
  Accreditation level                                    \<0.0001                                                 0.9082   0.003                     
  Medical center                                         1255                 41.04             1069   34.01      964      37.58   960    37.43      
  Non-medical center                                     1803                 58.96             2074   65.99      1601     62.42   1605   62.57      
  Ownership                                              \<0.0001                                                 0.6116   0.014                     
  Public hospital                                        730                  23.87             608    19.34      550      21.44   565    22.03      
  Non-public hospital                                    2328                 76.13             2535   80.66      2015     78.56   2000   77.97      
  Average annual breast cancer volume of the facility    \<0.0001                                                 0.9726   0.003                     
  Low                                                    1399                 45.75             1692   53.83      1269     49.47   1269   49.47      
  Median                                                 851                  27.83             766    24.37      674      26.28   680    26.51      
  High                                                   808                  26.42             685    21.79      622      24.25   616    24.02      

PCP: primary care physician; PSM: propensity score matching; COCI: continuity of care index; ER: estrogen receptor; PR: progesterone receptor; CCI: Charlson Comorbidity Index; BCS: breast cancer surgery. ^a^ The analytic sample included only the patients who made at least three visits for primary care physicians in the second year after diagnosis. ^b^ Insured income is lower than the level required for charging premium.
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###### 

Summary statistics for main interest variables according to follow-up period.

  -------------------------------------------------------------------------------------------------------------------------------
  Variable                                Follow-Up Period 1\   Follow-Up Period 2\   Follow-Up Period 3\   Follow-Up Period 4\
                                          (*n* = 18031)         (*n* = 16904)         (*n* = 15990)         (*n* = 15237)
  --------------------------------------- --------------------- --------------------- --------------------- ---------------------
  Continuity of care                      mean (SD)             mean (SD)             mean (SD)             mean (SD)

  Oncology COCI                           0.71 (0.28)           0.72 (0.29)           0.71 (0.29)           0.70 (0.30)

  PCP COCI                                0.52 (0.31)           0.54 (0.31)           0.54 (0.31)           0.54 (0.30)

  Follow-up service                       \%                    \%                    \%                    \%

  Mammography ^\#^                        56.63                 55.54                 56.77                 56.96

  Breast Ultrasound ^\#^                  74.63                 74.26                 73.13                 73.73

  Mammography or Breast Ultrasound ^\#^   79.89                 78.49                 77.55                 75.28

  Advanced Imaging Taking                 84.75                 83.62                 82.95                 82.18

  Health Outcome                          \%                    \%                    \%                    \%

  Hospitalization                         13.06                 10.59                 10.57                 10.92

  Emergency Department Use                12.03                 13.36                 14.13                 14.67
  -------------------------------------------------------------------------------------------------------------------------------

COCI: continuity of care index; PCP: primary care physician. ^\#^ Excludes women with a history of bilateral mastectomy.
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###### 

Generalized estimating equation models for the effect of continuity of care.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable            Mammography   Breast Ultrasound   Advanced\      Hospitalization   Emergency Department Use                                                                  
                                                        Imaging Test                                                                                                               
  ------------------- ------------- ------------------- -------------- ----------------- -------------------------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------
  Oncology COCI ^a^   1.26          1.19                1.32           1.12              1.06                       1.18   1.47   1.36   1.60   0.78   0.71   0.85   0.88   0.82   0.95

  PCP COCI ^a^        1.02          0.95                1.09           0.95              0.88                       1.03   1.01   0.93   1.10   0.77   0.70   0.85   0.75   0.68   0.82
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

COCI: Continuity of Care Index; PCP: Primary care physician; OR: Odds ratio; CI: Confidence interval. ^a^ Reference group is lower continuity of care. Using a generalized estimating equation model with binominal distribution with logit link. To avoid over-adjustment, we opted not to include in our analysis any variables that had been used in propensity score matching and had been balanced after matching.
